150557-06-5Relevant academic research and scientific papers
Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)
Matecka, Dorota,Rothman, Richard B.,Radesca, Lilian,De Costa, Brian R.,Dersch, Christina M.,Partilla, John S.,Pert, Agu,Glowa, John R.,Wojnicki, Francis H. E.,Rice, Kenner C.
, p. 4704 - 4716 (2007/10/03)
The design, synthesis, and biological evaluation of compounds related to the dopamine (DA) uptake inhibitors: 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (1) and 1-[2-[bis-(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (2) (GBR
THIAZOLIDINECARBOXYLIC ACID AMIDE DERIVATIVES AND THEIR THERAPEUTIC USES
-
, (2008/06/13)
Thiazolidinecarboxylic acid amides having combined antiallergic and antiasthmatic activities with an antagonist activity against platelet Activating Factor and having the following general formula (I) STR1
Pyridylthiazolidinecarboxylic acid amide derivatives, their preparation and their therapeutic uses
-
, (2008/06/13)
New pyridylthiazolinecarboxylic acid amide compounds have been found to have a valuable combination of antiallergic and antiasthmatic activities with an antagonist activity against Platelet Activating Factor.
